Ryan T. Merrell

Neurology
1500 21st Ave S Ste 1506
Nashville, TN 37212

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

Pembrolizumab, Temozolomide and HSPPC-96 Vaccine in Newly Diagnosed Glioblastoma Post-Chemoradiation: Results from a Multi-institutional, Phase 2, Randomized, Placebo-Controlled Trial.

Journal: medRxiv : the preprint server for health sciences
Published: July 03, 2026

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Combination of metronomic oral pazopanib and topotecan for recurrent glioblastoma with and without previous bevacizumab: Results from a phase 2 clinical trial.

Journal: Neuro-oncology advances
Published: June 24, 2025

Association of thyroid disease and intracranial meningiomas: a retrospective analysis with external validation.

Association of thyroid disease and intracranial meningiomas: a retrospective analysis with external validation.

Journal: Frontiers in oncology
Published: May 26, 2025

Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors.

Magnetic Resonance Spectroscopy of Cystathionine and 2-Hydroxyglutarate in Brain Tumors.

Journal: NMR in biomedicine
Published: May 15, 2025

Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas.

Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate and Glycine in Adult Subjects With Brainstem Gliomas.

Journal: NMR in biomedicine
Published: February 08, 2025

A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.

A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed MGMT-methylated malignant glioma.

Journal: Neuro-oncology advances
Published: February 29, 2024

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine.

Journal: Nature communications
Published: February 29, 2024

Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastoma.

Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastoma.

Journal: medRxiv : the preprint server for health sciences
Published: January 18, 2024

Optimization of the flip angles of narrow-band editing pulses in J-difference edited MRS of lactate at 3T.

Optimization of the flip angles of narrow-band editing pulses in J-difference edited MRS of lactate at 3T.

Journal: Magnetic resonance in medicine
Published: July 31, 2023

The genomic landscape of familial glioma.

The genomic landscape of familial glioma.

Journal: Science advances
Published: April 28, 2023

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.

Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.

Journal: Neuro-oncology advances
Published: February 23, 2023

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: January 12, 2023
Showing 1-12 of 44

Last Updated: 09/26/2026